Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and pheripherally acting 5HT1B/1D agonist : international clinical experience based on >3000 subjects treated with zolmitriptan
John G. Edmeads Artikkel Engelsk
*0011719300 *008980331s1997 xx# 000 0 eng *019 $bk *08230$a616.857 *100 $aEdmeads, John G.$_170269500 *245 $aTolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and pheripherally acting 5HT1B/1D agonist$binternational clinical experience based on >3000 subjects treated with zolmitriptan *300 $aS. [41]-52 *700 $aMillson, D.S.$_170269600 *773 $tCephalalgia$gVol. 17, suppl. 18 (1997)$x0333-1024$w(NO-LaBS)230658(tnr) *999 $z9800234447$anorart:9800234447 ^